Stock Events

Stock Events

Pyxis Oncology 

$1.8287
67
+$0.02+1.03% 12:13 Today

Statistics

Day High
1.835
Day Low
1.81
52W High
5.55
52W Low
1.03
Volume
72,604
Avg. Volume
-
Mkt Cap
150.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 17Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.62
-0.51
-0.39
-0.28
Expected EPS
-0.2782
Actual EPS
N/A

Financials

-574.55%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
13.86MRevenue
-79.62MNet Income

Analyst Ratings

$11.67Average Price Target
The highest estimate is ⁦19.00⁩.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PYXS. It's not an investment recommendation.
NVIDIA
10
NVDA
Schwab US Dividend Equity
10
SCHD
Bitcoin
10
BTC.CRYPTO
Vanguard S&P 500
9
VOO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a leading biopharmaceutical company focusing on cancer treatments, directly competing with Pyxis Oncology's focus on developing cancer therapies.
Merck
MRK
Mkt Cap368.89B
Merck & Co., Inc. is a global healthcare company that develops cancer drugs and immunotherapies, competing in the same oncology space as Pyxis Oncology.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. specializes in antiviral drugs and has expanded into oncology, making it a competitor in the cancer treatment market.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. is a biotech company focusing on human therapeutics, including oncology, which puts it in direct competition with Pyxis Oncology.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. is a global pharmaceutical corporation with a significant portfolio of oncology drugs, competing in the same market as Pyxis Oncology.
Novartis
NVS
Mkt Cap303.67B
Novartis AG is a multinational pharmaceutical company that has a strong focus on oncology, making it a competitor to Pyxis Oncology.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in oncology and personalized medicine, directly competing with Pyxis Oncology in the cancer treatment arena.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on oncology, respiratory, cardiovascular, and more, competing with Pyxis Oncology in the oncology sector.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. is known for its innovative treatments in areas including oncology, directly competing with Pyxis Oncology's research and development in cancer therapies.

About

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.
Show More
CEO
Thomas Civik
Employees
56
Country
United States
ISIN
US7473241013

Listings

XNAS
US
PYXS
BOATS
BOATS
PYXS.BOATS

0 Comments

Share your thoughts

FAQs

What is Pyxis Oncology stock price today?▼
The current price of PYXS is $1.83 USD — it has increased by +1.03% in the past 24 hours. Watch Pyxis Oncology stock price performance more closely on the chart.
What is Pyxis Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Pyxis Oncology stocks are traded under the ticker PYXS.
Is Pyxis Oncology stock price growing?▼
PYXS stock has risen by +7.1% compared to the previous week, the month change is a -15.42% fall, over the last year Pyxis Oncology has showed a -49.16% decrease.
What is Pyxis Oncology market cap?▼
Today Pyxis Oncology has the market capitalization of 150.97M
When is the next Pyxis Oncology earnings date?▼
Pyxis Oncology is going to release the next earnings report on November 17, 2026.
What were Pyxis Oncology earnings last quarter?▼
PYXS earnings for the last quarter are -0.4 USD per share, whereas the estimation was -0.35 USD resulting in a -14.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pyxis Oncology revenue for the last year?▼
Pyxis Oncology revenue for the last year amounts to 13.86M USD.
What is Pyxis Oncology net income for the last year?▼
PYXS net income for the last year is -79.62M USD.
How many employees does Pyxis Oncology have?▼
As of November 2, 2026, the company has 56 employees.
In which sector is Pyxis Oncology located?▼
Pyxis Oncology operates in the Health & Wellness sector.
When did Pyxis Oncology complete a stock split?▼
Pyxis Oncology has not had any recent stock splits.
Where is Pyxis Oncology headquartered?▼
Pyxis Oncology is headquartered in BOSTON, United States.